Get the Stockscreener App
1.44
2.04%
-0.03
After Hours:
1.40
-0.04
-2.78%
Alector Inc stock is traded at $1.44, with a volume of 1.64M.
It is down -2.04% in the last 24 hours and down -56.63% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.47
Open:
$1.46
24h Volume:
1.64M
Relative Volume:
0.65
Market Cap:
$145.75M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.1707
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
-4.00%
1M Performance:
-56.63%
6M Performance:
+10.77%
1Y Performance:
-71.31%
1-Day Range:
$1.39
$1.50
1-Week Range:
$1.39
$1.68
52-Week Range:
$0.87
$6.14
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.44 | 148.78M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Full technical analysis of Alector Inc. stockInflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Lost Investment in Alector, Inc. (ALEC)? Levi & Korsinsky Launches Securities Fraud Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Alector, Inc. (ALEC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Why Alector Inc. (0Z2) stock attracts wealthy investorsRisk Management & Technical Pattern Based Buy Signals - newser.com
Is Alector Inc. (0Z2) stock supported by strong fundamentalsPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
Will Alector Inc. stock maintain dividend yieldJuly 2025 Breakouts & Weekly High Return Opportunities - newser.com
Why Alector Inc. stock remains undervalued2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
Why Alector Inc. stock remains a top recommendationStock Surge & Free High Accuracy Swing Entry Alerts - newser.com
Is Alector Inc. (0Z2) stock resilient in recession scenariosJuly 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
How to track smart money flows in Alector Inc.2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Why Alector Inc. (0Z2) stock is a strong buy call2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com
Volatility clustering patterns for Alector Inc.2025 Market Overview & Breakout Confirmation Alerts - newser.com
Is Alector Inc. stock attractive for growth ETFsCEO Change & Short-Term Trading Opportunity Alerts - newser.com
Backtesting results for Alector Inc. trading strategiesTrade Risk Summary & Fast Moving Stock Watchlists - newser.com
Will Alector Inc. stock attract ESG investorsTrade Entry Summary & Scalable Portfolio Growth Ideas - newser.com
Evaluating Alector Inc. with trendline analysisWeekly Trend Report & Fast Moving Market Watchlists - newser.com
ALEC Investor Notice: Levi & Korsinsky Investigates Alector, Inc. for Securities Law Violations - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alector, Inc. (ALEC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
How Alector Inc. (0Z2) stock compares with market leadersPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Why Alector Inc. stock attracts global investorsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Alector, Inc. (ALEC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Alector, Inc. (ALEC) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2025-10-31 | Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ALEC | Press Release - Stockhouse
Is Alector Inc. stock a defensive play in 2025Quarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Can Alector Inc. (0Z2) stock hold up in economic slowdown2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Alector Announces Topline Results from Phase 3 INFRONT-3 Clinical Trial Evaluating Latozinemab - Insider Monkey
How to build a dashboard for Alector Inc. stock2025 Year in Review & Verified Stock Trade Ideas - newser.com
Is Alector Inc a good long term investmentTrend Following Strategies & High Return Trading Portfolio - earlytimes.in
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment - TipRanks
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alector, Inc. (ALEC) And Encourages Investors to Connect - ACCESS Newswire
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):